FGF5 and esophageal squamous cell carcinoma: The importance of FGF5 expression for resistance to dCRT suggests that inhibition of FGF5 or its pathway may have therapeutic benefit in increasing the response to dCRT of ESCC, especially when FGF5 is not methylated.